scholarly journals Fetal Pathology Findings Domain

2020 ◽  
Author(s):  
Keyword(s):  
Fetal Pathology

Clinical utility of Shabda and Sparsha Pareeksha in evaluation of Prakruta and Vaikruta Garbhavastha

2016 ◽  
Vol 1 (2) ◽  
Author(s):  
Priyanka T K ◽  
V.N. K. Usha ◽  
Sucheta Kumari M
Keyword(s):  
Clinical Study ◽  
Clinical Utility ◽  
Neonatal Outcome ◽  
Predictive Accuracy ◽  
Cost Effective ◽  
Well Being ◽  
Prospective Clinical Study ◽  
Clinical Tool ◽  
Accuracy Rate ◽  
Fetal Pathology

Garbha is a conglomeration of biological mass with different strata including consciousness, needs an innovative clinical tool to evaluate its well being, which proves safe, potent, cost-effective and noninvasive. The idea of taking up this study was to sensitively predict the Prakrutavastha or well being w.r.t Garbha-pushti and ongoing Fetal Pathology, Vaikrutavastha w.s.r Garbhavyapads for a sharp interference to get a possible best neonatal outcome. The objective of this study was to calculate the predictive accuracy of evaluation of Garbhaspandanam on external Shabda and Sparsha Pareeksha. A Prospective Clinical study of Garbhaspandanam (FHS and FM) with external Shabda and Sparsha stimulation on maternal abdomen, from 24th week onwards was conducted in a cohort of 30 Singleton Pregnant women at Dept. of Prasuti Tantra and Stri Roga, S.D.M.C.A. Hospital, Udupi. Among the 9 cases in abnormal category, 2 cases had gone for IUD and one case though placed in abnormal category had responded relatively well to Shabda and Sparsha Pareeksha which may be due to the proper antenatal care and intervention given along with the patient’s Vatakara Nidana Parivarjana. Predictive Accuracy Rate on Shabda and Sparsha Pareeksha showed, FHS 70%, FM 76.7%; FHS 73.3%, FM 66.7% respectively. Shabda and Sparshapareeksha can be utilized as the Garbha - chetana - dyodakalakshana and can be performed as a routine antenatal bedside procedure, which can fairly detect the Prakruta and Vaikrutavastha of Garbha w.r.t Pushti. However larger prospective studies are required.

Intrauterine manometry: Technique and application to fetal pathology

1989 ◽  
Vol 9 (4) ◽  
pp. 243-254 ◽  
Author(s):  
Umberto Nicolini ◽  
Nicholas M. Fisk ◽  
David G. Talbert ◽  
Charles H. Rodeck ◽  
Neil K. Kochenour ◽  
...  
Keyword(s):  
Fetal Pathology

Embryo and fetal pathology: A color atlas with ultrasound correlations

2004 ◽  
Vol 35 (10) ◽  
pp. 1297-1298
Author(s):  
Virginia A. Livolsi
Keyword(s):  
Fetal Pathology

Fetal Pathology

2015 ◽  
pp. 583-602
Author(s):  
Jeremy W Pryce ◽  
Neil J Sebire
Keyword(s):  
Fetal Pathology

Clinical significance of predictive and diagnostic indices of fetal pathology associated with placental insufficiency in women with endometriosis

2021 ◽  
Vol 70 (5) ◽  
pp. 37-48
Author(s):  
Igor S. Lipatov ◽  
Yury V. Tezikov ◽  
Mikhail S. Amosov
Keyword(s):  
Pregnant Women ◽  
Growth Retardation ◽  
Pregnancy Complications ◽  
Placental Insufficiency ◽  
Information Value ◽  
Placental Alkaline Phosphatase ◽  
Fetal Hypoxia ◽  
Ovarian Endometriosis ◽  
Group I ◽  
Fetal Pathology

BACKGROUND: Modern achievements of pharmacology, surgery and reproductive medicine have determined an increase in the implementation of reproductive function in endometriosis of various localization. The onset of pregnancy in presence of impaired endometrial receptivity and progesterone resistance, pro-inflammatory and pro-thrombotic status, abnormal functioning of the immune system, structural changes in the reproductive organs leads to impaired formation of the embryo (feto) placental system, early reproductive losses, complicated pregnancy and adverse perinatal outcomes. In this regard, the endometriosis and pregnancy issue requires close study and specific proposals to optimize pregnancy management. AIM: The aim of this study was to develop predictive (PIs) and diagnostic (DIs) indices of placenta-associated fetal pathology in pregnant women with endometriosis, to determine their prognostically and diagnostically significant parameters. MATERIALS AND METHODS: This prospective study in the dynamics of gestation included a comprehensive clinical and laboratory examination of 175 pregnant women with endometriosis (100 subjects with adenomyosis and 75 subjects with ovarian endometriosis). To develop PIs and DIs, two comparison groups with fetal pathology due to placental insufficiency were retrospectively identified, depending on the location of endometriosis. Group I consisted of 49 pregnant women with adenomyosis and placental insufficiency isolated from other pregnancy complications, accompanied by growth retardation and/or chronic fetal hypoxia; Group II comprised 29 pregnant women with ovarian endometriosis and placental insufficiency isolated from other pregnancy complications, accompanied by growth retardation and/or chronic fetal hypoxia. The control group (Group III) included 30 healthy pregnant women with a normal course of gestation. The examination was performed at 10-14 weeks, 20-24 weeks, and 28-34 weeks of gestation and included an assessment of placental insufficiency markers such as placental growth factor (PlGF), placental -1-microglobulin (PAMG-1), tumor necrosis factor (TNF), lymphocytes with membrane receptor FasR (L CD95+), C-reactive protein, placental alkaline phosphatase (PAPh), and fetal hemoglobin (HbF). The information value of individual parameters and indices was determined by ROC analysis, odds ratio, and clinical epidemiology tests. RESULTS: Pregnancy in presence of endometriosis in 100% of cases was complicated by placental insufficiency of varying severity (with fetal pathology in 81.5% of cases), the frequency of which had statistically significant differences between the groups of pregnant women with adenomyosis and ovarian endometriosis (2 = 4.06, p = 0.04). To predict growth retardation and / or chronic fetal hypoxia, we have developed PI I (PlGF / TNF 100) and PI II (PAMG-1 / PlGF 100), which characterize the state of placental angio-and vasculogenesis depending on systemic inflammatory response level. For early diagnosis of fetal pathology, we have proposed DI I (CRP / PAPh 100), DI II (HbF / PlGF 100) and DI III (L CD95+ / PAPh 100), which allow for diagnosing placental alterations with impaired placental energy supply due to an increase in inflammatory status. Evaluation of prognostic and diagnostic significance of PIs and DIs showed that the most informative tools are PI I (Se = 86.1%, Sp = 80.5%) and DI I (Se = 88.3%, Sp = 83.7%). CONCLUSIONS: The use of PIs allows for risk stratification of pregnant women from the 1st trimester of gestation to address the issue of the prevention method. The clinical capabilities of DIs optimize obstetric tactics for the timely prescription of therapy for placental insufficiency and targeted diagnosis of fetal pathology. Pregnant women with endometriosis should be classified as a high perinatal risk group, and therefore the proposed PIs and DIs should be included in the dynamic examination complex.

Fetal pathology produced by ethylene oxide treatment of the murine zygote

Teratology ◽  
1989 ◽  
Vol 39 (6) ◽  
pp. 563-572 ◽  
Author(s):  
Joe C. Rutledge ◽  
Walderico M. Generoso
Keyword(s):  
Ethylene Oxide ◽  
Fetal Pathology

FREE RADICALS AND FETAL PATHOLOGY

1994 ◽  
Vol 22 (s1) ◽  
pp. 39-42 ◽  
Author(s):  
U.M. Marinari ◽  
N. Traverso ◽  
G. Maloberti ◽  
M.A. Pronzato
Keyword(s):  
Free Radicals ◽  
Fetal Pathology

Fetal Pathology

1996 ◽  
Vol 20 (9) ◽  
pp. 1157
Author(s):  
Kathleen P. Heidelberger
Keyword(s):  
Fetal Pathology
Sign in / Sign up

Export Citation Format

Share Document